Kumamaru Hirotani, the vice director of Aoi Hospital in Kawasaki, stated that nicotine replacement therapy (NRT), such as nicotine patches, did not produce the expected results. However, since the introduction of heated tobacco products (HTP) locally, smoking rates have significantly decreased.
In summary, they did not see great success with nicotine replacement therapies. However, since 2014, three heated tobacco products have been officially introduced nationwide in Japan and have penetrated 25% of the total smoking population. As a result, the smoking rate in Japan has successfully decreased over the past three to four years, according to Hiroya in a recent online seminar.
Research Shows That Heating Tobacco Products Decreases Cigarette Sales by 34%
Frost & Sullivan recently collaborated with tobacco company Philip Morris International (PMI) to publish a paper titled "Reducing Tobacco Harms and Novel Nicotine and Tobacco Products: Evidence from the Japanese Market". The paper reflects their argument that the introduction of HTP has led to a 34% decrease in cigarette sales.
The commercial viability of Japanese HTP is strongly linked to the significant decline in traditional cigarette sales, surpassing previous rates of decline. Furthermore, even with the introduction of heated tobacco products, all tobacco products (both heated tobacco and traditional cigarettes) continue to experience a decrease in sales. While evidence is mixed, data from the 2019 National Health Survey suggests that 76% of consumers only use heated tobacco products, with only 24% of HTP users maintaining dual use," stated Mark Dougan, Healthcare Consulting Director at Frost & Sullivan.
According to him, the Japanese government distinguishes HTP from traditional cigarettes in terms of tax, health warnings, and indoor usage restrictions, and the regulatory framework for heated tobacco products is usually more lenient than for traditional cigarettes.
Statement:
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the viewpoint of 2FIRSTS and 2FIRSTS is unable to confirm the authenticity or accuracy of the contents of the article. The compilation of this article is solely intended for industry exchange and research.
Due to limitations in the compiling ability, the translated article may not fully express the original text. Please refer to the original text for accuracy.
2FIRSTS remains completely aligned with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or international statements and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
